A detailed history of Hamilton Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hamilton Wealth, LLC holds 21,229 shares of ABBV stock, worth $4.97 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
21,229
Holding current value
$4.97 Million
% of portfolio
1.16%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$184.85 - $231.54 $3.92 Million - $4.92 Million
21,229 New
21,229 $4.92 Million
Q2 2025

Nov 14, 2025

SELL
$170.16 - $206.27 $197,385 - $239,273
-1,160 Closed
0 $0
Q1 2025

Nov 14, 2025

BUY
$169.2 - $216.66 $196,272 - $251,325
1,160 New
1,160 $243,000
Q3 2020

Oct 21, 2020

SELL
$85.91 - $100.83 $1.83 Million - $2.15 Million
-21,349 Closed
0 $0
Q2 2020

Jul 24, 2020

SELL
$73.37 - $98.18 $1.32 Million - $1.77 Million
-18,036 Reduced 45.79%
21,349 $2.1 Million
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $2.54 Million - $3.85 Million
39,385 New
39,385 $3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hamilton Wealth, LLC Portfolio

Follow Hamilton Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Wealth, LLC with notifications on news.